Biopharmaceutical company interrogating stem cell biology
Advocated for funding to advance from basic research to clinical readiness a first generation stem cell medicine for muscle regeneration and traumatic brain injury by using the fundamental biological mechanisms that guide cell fate to develop innovative therapeutics. Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health. Advocated for funding to advance from basic research to clinical readiness a first generation stem cell medicine for muscle regeneration and traumatic brain injury by using the fundamental biological mechanisms that guide cell fate to develop innovative therapeutics. Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health. Advocated for funding to advance from basic research to clinical readiness a first generation stem cell medicine for muscle regeneration and traumatic brain injury by using the fundamental biological mechanisms that guide cell fate to develop innovative therapeutics. Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health.
MED - Medical/Disease Research/Clinical Labs BUD - Budget/Appropriations DEF - Defense
116 - Defense Advanced Research Projects Agency (DARPA) 25 - Defense, Dept of (DOD) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 116 - Defense Advanced Research Projects Agency (DARPA) 25 - Defense, Dept of (DOD) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 116 - Defense Advanced Research Projects Agency (DARPA) 25 - Defense, Dept of (DOD) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE PETRIZZO GROUP, INC.
601 New Jersey Ave NW, Suite 830, Washington, DC, 20001, US
TJ PETRIZZO PHILLIP J BOND TJ PETRIZZO PHILLIP J BOND TJ PETRIZZO TRICIA BARRENTINE GUAY PHILLIP J BOND